Drug:
Reaction: GENERAL PHYSICAL HEALTH DETERIORATION
20250101 - 20251231
No. 1701 - 1800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1701 | 24875087 |
PL |
16 | 1 |
General physical health deterioration, Off label use, |
||||
VENETOCLAX, VENETOCLAX, ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, IMATINIB, |
||||
| 1702 | 24875147 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1703 | 24875294 |
AT |
57 | 1 |
Amyloidosis, Quadriplegia, Therapeutic product effect incomplete, General physical health deterioration, Hypertension, Off label use, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CARFILZOMIB, DARATUMUMAB, |
||||
| 1704 | 24875330 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1705 | 24875383 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1706 | 24875467 |
JP |
77 | 1 |
Corneal perforation, Anterior chamber disorder, Iris adhesions, Conjunctivitis, Intraocular pressure fluctuation, General physical health deterioration, |
||||
NIVOLUMAB, |
||||
| 1707 | 24875683 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1708 | 24875840 |
CA |
1 | |
Seizure, Erectile dysfunction, Asthenia, Blood testosterone decreased, Bone pain, Burning sensation, Chills, Depression, Seborrhoeic keratosis, Dyspnoea, Erythema, General physical health deterioration, Haemoglobin abnormal, Headache, Heart rate increased, Hot flush, Hyperhidrosis, Hypoaesthesia, Hypogonadism, Loss of libido, Nervousness, Osteoporosis, Pruritus, Red blood cell count decreased, Respiration abnormal, White blood cell count increased, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 1709 | 24864699 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1710 | 24864769 |
US |
93 | 1 |
Sepsis, Weight decreased, Diarrhoea, Pneumonia, Gastrointestinal tube insertion, Device occlusion, General physical health deterioration, |
||||
PANCRELIPASE, PANCRELIPASE, |
||||
| 1711 | 24864787 |
US |
1 | |
General physical health deterioration, |
||||
APADAMTASE ALFA, |
||||
| 1712 | 24864801 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1713 | 24864829 |
CA |
47 | 1 |
Knee operation, Back pain, Neck pain, General physical health deterioration, Off label use, |
||||
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, |
||||
| 1714 | 24864951 |
US |
||
Pneumonia, General physical health deterioration, |
||||
SODIUM ZIRCONIUM CYCLOSILICATE, |
||||
| 1715 | 24865053 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1716 | 24865054 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1717 | 24865089 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1718 | 24865481 |
US |
37 | 2 |
Drug ineffective, General physical health deterioration, |
||||
DASATINIB, PONATINIB HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, TIRZEPATIDE, MIDODRINE HYDROCHLORIDE, RIVAROXABAN, CLOPIDOGREL, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, ACETAMINOPHEN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, BELUMOSUDIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, RUXOLITINIB, CALCIUM, ALLOPURINOL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MUPIROCIN, MUPIROCIN CALCIUM, BACLOFEN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ACYCLOVIR, |
||||
| 1719 | 24865740 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1720 | 24865883 |
CA |
80 | 1 |
Respiration abnormal, Oxygen saturation decreased, Death, Intentional product misuse, General physical health deterioration, |
||||
PIRFENIDONE, |
||||
| 1721 | 24865950 |
JP |
93 | 1 |
Multiple organ dysfunction syndrome, Marasmus, Loss of consciousness, General physical health deterioration, |
||||
| 1722 | 24866708 |
BR |
56 | 1 |
Blood glucose increased, Product distribution issue, Blood glucose increased, Nervousness, Dry mouth, Dizziness, Blood glucose increased, Product use in unapproved indication, Product use issue, Blood glucose increased, Feeling abnormal, Depressed mood, Arrhythmia, Depression, Illness, General physical health deterioration, Product blister packaging issue, |
||||
EMPAGLIFLOZIN AND LINAGLIPTIN, EMPAGLIFLOZIN AND LINAGLIPTIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 1723 | 24866827 |
US |
||
Pancytopenia, General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1724 | 24866868 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1725 | 24867044 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1726 | 24867092 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1727 | 24867302 |
CA |
43 | 2 |
Abdominal pain, Abdominal pain upper, Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Condition aggravated, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Infection, Inflammation, Infusion related reaction, Infusion site reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse drug reaction, Adverse event, Live birth, Drug intolerance, Exposure during pregnancy, Maternal exposure during pregnancy, Drug ineffective, Treatment failure, Therapeutic product effect incomplete, Therapeutic product effect decreased, Intentional product use issue, Contraindicated product administered, Off label use, Product quality issue, Product use in unapproved indication, Product use issue, Product label confusion, Coeliac disease, Dyspepsia, Grip strength decreased, Insomnia, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, SECUKINUMAB, SECUKINUMAB, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, MEPOLIZUMAB, TRETINOIN, |
||||
| 1728 | 24867343 |
SE |
44 | 2 |
Headache, Abdominal pain, Dizziness, Alanine aminotransferase increased, General physical health deterioration, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 1729 | 24867482 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1730 | 24867505 |
EU |
57 | 1 |
Amyloidosis, Quadriplegia, Therapeutic product effect incomplete, General physical health deterioration, Hypertension, Off label use, |
||||
DEXAMETHASONE SODIUM PHOSPHATE, DARATUMUMAB, CARFILZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 1731 | 24867547 |
CA |
1 | |
Inguinal hernia, Gastrointestinal disorder, General physical health deterioration, Diarrhoea, |
||||
ADALIMUMAB-ADAZ, |
||||
| 1732 | 24868295 |
US |
1 | |
General physical health deterioration, Malaise, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
| 1733 | 24868353 |
CA |
67 | 2 |
Spinal operation, Osteoporosis, General physical health deterioration, Pain, Osteoarthritis, Pain in extremity, Arthralgia, |
||||
ADALIMUMAB-ADAZ, |
||||
| 1734 | 24868539 |
DE |
73 | 2 |
Nervous system disorder, Acute kidney injury, Hypertension, Polyneuropathy, Gout, Hyponatraemia, General physical health deterioration, Confusional state, Hallucination, Hypophagia, Metabolic acidosis, Hyperkalaemia, Loss of consciousness, Cardiac arrest, Shock symptom, Resuscitation, Fluid intake reduced, Chronic kidney disease, Dehydration, Discoloured vomit, Acute kidney injury, Respiratory failure, Cardiac failure, Hepatic failure, General symptom, |
||||
UPADACITINIB, BISOPROLOL FUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SIMVASTATIN, ENALAPRIL, EMPAGLIFLOZIN, |
||||
| 1735 | 24868984 |
CA |
1 | |
Ankylosing spondylitis, General physical health deterioration, |
||||
ADALIMUMAB-ADAZ, |
||||
| 1736 | 24869096 |
CA |
2 | |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blister, Blood cholesterol increased, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Eye injury, Fatigue, Fibromyalgia, Folliculitis, Gait disturbance, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hip arthroplasty, Hypersensitivity, Hypertension, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint swelling, Knee arthroplasty, Liver disorder, Loss of personal independence in daily activities, Lower respiratory tract infection, Lupus vulgaris, Maternal exposure during pregnancy, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Off label use, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Prescribed overdose, Prescribed underdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriatic arthropathy, Pulmonary fibrosis, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Ulcer haemorrhage, Urticaria, Vomiting, Wheezing, Wound, Insomnia, Pyrexia, Sleep disorder, Sinusitis, Weight increased, Autoimmune disorder, Decreased appetite, Deep vein thrombosis postoperative, Gait inability, Hypoaesthesia, Incorrect route of product administration, Stomatitis, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PHENYLEPHRINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, |
||||
| 1737 | 24869487 |
AT |
57 | 1 |
Amyloidosis, Quadriplegia, Therapeutic product effect incomplete, General physical health deterioration, Hypertension, Off label use, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB, CARFILZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 1738 | 24869678 |
IT |
63 | 1 |
Diarrhoea, Syncope, Electrocardiogram ST-T segment abnormal, General physical health deterioration, Drug intolerance, |
||||
OXALIPLATIN, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, TUCATINIB, FLUOROURACIL, FLUOROURACIL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PANTOPRAZOLE, ENOXAPARIN SODIUM, |
||||
| 1739 | 24869842 |
FR |
92 | 2 |
General physical health deterioration, Vomiting, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 1740 | 24869951 |
CA |
34 | 2 |
Pain, Alopecia, General physical health deterioration, Normal newborn, Maternal exposure during pregnancy, |
||||
CERTOLIZUMAB PEGOL, HYDROXYCHLOROQUINE, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, |
||||
| 1741 | 24870418 |
CA |
44 | 2 |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, C-reactive protein increased, Colitis ulcerative, Condition aggravated, Confusional state, Contusion, Crohn^s disease, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug tolerance decreased, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Ear infection, Exostosis, Facet joint syndrome, Fatigue, Feeling hot, Fibromyalgia, Folliculitis, Foot deformity, Frequent bowel movements, Gait disturbance, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Ill-defined disorder, Hypoaesthesia, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Knee arthroplasty, Laboratory test abnormal, Laryngitis, Pemphigus, Prescribed overdose, Product use in unapproved indication, Product use issue, Psoriasis, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sleep disorder, Swelling, Live birth, Liver injury, Malaise, Maternal exposure during pregnancy, Contraindicated product administered, Disability, Drug ineffective, Drug intolerance, Exposure during pregnancy, Intentional product use issue, Memory impairment, Mobility decreased, Muscular weakness, Musculoskeletal stiffness, Nausea, Oedema, Off label use, Pain, Pemphigus, Swollen joint count increased, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Treatment noncompliance, Type 2 diabetes mellitus, Vomiting, Walking aid user, Weight decreased, Wheezing, Wound, Wound infection, Pericarditis, Adverse drug reaction, Adverse event, Synovitis, |
||||
APREPITANT, FOSAPREPITANT DIMEGLUMINE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, |
||||
| 1742 | 24870486 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1743 | 24870487 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1744 | 24870488 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1745 | 24870812 |
US |
57 | 1 |
Urinary incontinence, General physical health deterioration, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
| 1746 | 24860242 |
IT |
||
General physical health deterioration, Urinary tract infection, |
||||
DAPAGLIFLOZIN, |
||||
| 1747 | 24860496 |
DE |
||
Thinking abnormal, Suicidal ideation, Seizure, Generalised tonic-clonic seizure, Bradykinesia, Electroencephalogram abnormal, General physical health deterioration, Polydipsia, Panic attack, Nightmare, Rash, Tremor, Depression, Drug ineffective, |
||||
ZONISAMIDE, ETHOSUXIMIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, OXCARBAZEPINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LACOSAMIDE, |
||||
| 1748 | 24860774 |
US |
83 | 1 |
General physical health deterioration, Adverse drug reaction, |
||||
AVAPRITINIB, |
||||
| 1749 | 24860791 |
CA |
2 | |
Death, Pneumonia, Fall, Asthenia, General physical health deterioration, |
||||
LENALIDOMIDE, |
||||
| 1750 | 24860795 |
VE |
1 | |
Chronic myeloid leukaemia recurrent, Leukocytosis, Anaemia, General physical health deterioration, Product availability issue, |
||||
| 1751 | 24861440 |
US |
2 | |
Hospitalisation, Recalled product administered, Out of specification test results, General physical health deterioration, |
||||
NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, |
||||
| 1752 | 24861449 |
DE |
57 | 2 |
Hepatitis E, Plasma cell myeloma, Gingival hypertrophy, General physical health deterioration, |
||||
ELOTUZUMAB, ELOTUZUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CARFILZOMIB, ISATUXIMAB, |
||||
| 1753 | 24862048 |
FR |
55 | 1 |
General physical health deterioration, C-reactive protein increased, Hyperleukocytosis, |
||||
PEMETREXED DISODIUM, CARBOPLATIN, PEMBROLIZUMAB, |
||||
| 1754 | 24862141 |
DE |
1 | |
General physical health deterioration, Drug ineffective, Infusion site hypertrophy, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 1755 | 24862209 |
US |
1 | |
Dystonia, COVID-19, Gait disturbance, Micturition disorder, General physical health deterioration, Back pain, Anxiety, |
||||
LECANEMAB, RISPERIDONE, RISPERIDONE, RISPERIDONE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, |
||||
| 1756 | 24862611 |
FI |
53 | 1 |
Depressed level of consciousness, Burning sensation, Dizziness, General physical health deterioration, Syncope, Skin reaction, Contusion, Vertigo, Viral infection, Headache, Blister, Skin lesion, Fatigue, Somnolence, |
||||
IVERMECTIN, |
||||
| 1757 | 24862817 |
JP |
7 | 1 |
Tracheostomy, Post procedural haemorrhage, General physical health deterioration, |
||||
EMICIZUMAB, |
||||
| 1758 | 24863189 |
US |
31 | 1 |
Knee arthroplasty, Depressed mood, Loss of personal independence in daily activities, General physical health deterioration, Pain, Inappropriate schedule of product administration, |
||||
BELUMOSUDIL, IBRUTINIB, |
||||
| 1759 | 24863871 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1760 | 24863941 |
US |
||
Ill-defined disorder, General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1761 | 24863959 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1762 | 24864068 |
CA |
50 | 2 |
Mobility decreased, Migraine, Upper respiratory tract infection, Nausea, Sleep disorder due to general medical condition, hypersomnia type, Feeling hot, Crohn^s disease, Colitis ulcerative, Hepatic cirrhosis, Red blood cell sedimentation rate increased, C-reactive protein, Gait inability, Folliculitis, Fibromyalgia, Fibromyalgia, Fatigue, Facet joint syndrome, Dyspnoea, Duodenal ulcer perforation, Dry mouth, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Drug hypersensitivity, Blister, Decreased appetite, Discomfort, Headache, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Joint range of motion decreased, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Irritable bowel syndrome, Joint swelling, Lip dry, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, OXYCODONE, OXYCODONE, OXYCODONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, DICLOFENAC SODIUM, PANTOPRAZOLE, PANTOPRAZOLE, PREGABALIN, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, SECUKINUMAB, SECUKINUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, INFLIXIMAB, INFLIXIMAB, CALCIUM CARBONATE, IBUPROFEN, LEUCOVORIN CALCIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, FOLIC ACID, FOLIC ACID, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, RAMIPRIL, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, VITAMIN C, PREDNISONE, CALCIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, LISINOPRIL, PIROXICAM, LANSOPRAZOLE, RISEDRONATE SODIUM, CAFFEINE, DESOGESTREL AND ETHINYL ESTRADIOL, ERGOCALCIFEROL, LANSOPRAZOLE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RISEDRONATE SODIUM, SULFASALAZINE, FISH OIL, |
||||
| 1763 | 24864319 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1764 | 24864320 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1765 | 24864348 |
CH |
78 | 1 |
Bursitis, Stoma site erythema, General physical health deterioration, Incorrect route of product administration, Stoma site discharge, Therapeutic product effect decreased, Fall, |
||||
| 1766 | 24864369 |
CA |
40 | 2 |
Abdominal pain upper, Helicobacter infection, Coeliac disease, Wound, Wound infection, Urticaria, Injection site reaction, Osteoarthritis, Peripheral swelling, Paraesthesia, Peripheral venous disease, Swelling, Sleep disorder, Taste disorder, Weight increased, C-reactive protein increased, Wheezing, Confusional state, Drug hypersensitivity, Onychomadesis, Gait inability, Product quality issue, Hepatic enzyme, Headache, Folliculitis, Abdominal pain, Asthenia, Blepharospasm, Blister, Breast cancer stage III, Depression, Discomfort, Dizziness, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fibromyalgia, Gastrointestinal disorder, General physical health deterioration, Grip strength decreased, Glossodynia, Hand deformity, Hepatic enzyme increased, Obesity, Off label use, Product use in unapproved indication, Vomiting, Live birth, Maternal exposure during pregnancy, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CANDESARTAN, OXYCODONE, OXYCODONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRAMADOL HYDROCHLORIDE, ETANERCEPT, ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE, MINOCYCLINE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TRAMADOL HYDROCHLORIDE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, MEPOLIZUMAB, RANITIDINE, TOPIRAMATE, TOPIRAMATE SPINKLE, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, SARILUMAB, NICOTINAMIDE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, |
||||
| 1767 | 24864591 |
CA |
1 | |
General physical health deterioration, |
||||
LEUPROLIDE ACETATE, |
||||
| 1768 | 24864674 |
CA |
40 | 2 |
Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Diarrhoea, Back injury, Musculoskeletal stiffness, Gastrooesophageal reflux disease, Swelling, Synovitis, Muscular weakness, Hypercholesterolaemia, Exposure during pregnancy, Normal newborn, Product label confusion, Off label use, Asthenia, Blepharospasm, Blister, Breast cancer stage III, Depression, Dizziness, Dry mouth, Duodenal ulcer perforation, Facet joint syndrome, Gait inability, General physical health deterioration, Hand deformity, Vomiting, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CANDESARTAN, OXYCODONE, OXYCODONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRAMADOL HYDROCHLORIDE, ETANERCEPT, ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, USTEKINUMAB, CALCIUM, CALCIUM, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, CALCIUM CARBONATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, AZATHIOPRINE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, ERGOCALCIFEROL, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, HYDROCORTISONE BUTYRATE, TOFACITINIB, POVIDONE-IODINE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, VITAMIN A, THIAMINE HYDROCHLORIDE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, GOLIMUMAB, VITAMIN C, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ATOMOXETINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MINOCYCLINE HYDROCHLORIDE, APREMILAST, APREMILAST, APREMILAST, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, APREMILAST, APREMILAST, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METHOTREXATE SODIUM, HYDROCORTISONE SODIUM SUCCINATE, ASCORBIC ACID, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, TETRACYCLINE HYDROCHLORIDE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, HYDROCORTISONE, HYDROCORTISONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, SARILUMAB, SARILUMAB, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, MINOCYCLINE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RANITIDINE HYDROCHLORIDE, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, DESOGESTREL AND ETHINYL ESTRADIOL, NAPROXEN, NAPROXEN SODIUM, BUPRENORPHINE, |
||||
| 1769 | 24859666 |
US |
1 | |
Hospitalisation, General physical health deterioration, Asthenia, |
||||
SUCROFERRIC OXYHYDROXIDE, |
||||
| 1770 | 24859764 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1771 | 24859955 |
CA |
||
Anxiety, Blood pressure fluctuation, Blood pressure increased, Condition aggravated, Depression, Frustration tolerance decreased, General physical health deterioration, Hepatic enzyme increased, Illness, Inappropriate schedule of product administration, Loss of consciousness, Injection site rash, Migraine, Stress, Urticaria, Pruritus, Hypersensitivity, Rash, Anaphylactic reaction, Heart rate increased, Hypotension, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, OMALIZUMAB, OMALIZUMAB, EPINEPHRINE, ADRENALINUM, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, DICLOFENAC, DICLOFENAC SODIUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, FAMOTIDINE, LORAZEPAM, RIZATRIPTAN BENZOATE, METHYLPREDNISOLONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, RIZATRIPTAN BENZOATE, |
||||
| 1772 | 24858615 |
CA |
80 | 1 |
Abdominal distension, Abdominal pain, Abdominal pain upper, Activated partial thromboplastin time prolonged, Anaemia, Antacid therapy, Anticoagulant therapy, Aortic stenosis, Appendicitis, Appendicolith, Ascites, Aspartate aminotransferase increased, Aspiration, Asthenia, Asthma, Bacterial infection, Benign prostatic hyperplasia, Breath sounds abnormal, Bronchiectasis, Bronchopulmonary aspergillosis allergic, Cardiogenic shock, Chronic obstructive pulmonary disease, Condition aggravated, Congenital hiatus hernia, Constipation, Coronary artery disease, Cough, Death, Diabetes mellitus, Drug ineffective, Drug intolerance, Dry mouth, Dyspnoea, End stage renal disease, Fatigue, Full blood count abnormal, Gastrooesophageal reflux disease, General physical health deterioration, Gout, Haemoptysis, Headache, Hyperlipidaemia, Hyperphosphataemia, Hyponatraemia, Hypophosphataemia, Hypoxia, Incorrect route of product administration, Intentional product misuse, Iron deficiency, Joint injury, Lower respiratory tract infection, Lung opacity, Malignant melanoma in situ, Micturition urgency, Multiple organ dysfunction syndrome, Musculoskeletal stiffness, Myasthenia gravis, Nausea, Neuralgia, Obstructive airways disorder, Oedema peripheral, Off label use, Pain, Pleural effusion, Pleuritic pain, Pneumonia, Product dose omission issue, Product use in unapproved indication, Pulmonary embolism, Pulmonary fibrosis, Pulmonary mass, Pyrexia, Rales, Sepsis, Sleep disorder, Sleep disorder therapy, Somnolence, Sputum discoloured, Stress, Swelling, Thrombosis, Total lung capacity decreased, Tremor, Upper respiratory tract infection, Ventricular fibrillation, Vomiting, Wheezing, Drug hypersensitivity, |
||||
NITROGLYCERIN, BUDESONIDE, HYDROCORTISONE, EFINACONAZOLE, IPRATROPIUM BROMIDE, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, MESALAMINE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, PHYTONADIONE, RAMIPRIL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, RAMIPRIL, RAMIPRIL, RAMIPRIL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, PHYTONADIONE, PHYTONADIONE, PHYTONADIONE, PHYTONADIONE, PHYTONADIONE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, |
||||
| 1773 | 24858676 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1774 | 24858985 |
US |
76 | 2 |
General physical health deterioration, Pneumonia, Dyspnoea, Off label use, |
||||
TREPROSTINIL, TREPROSTINIL, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, PREDNISONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LISINOPRIL, AMOXICILLIN, AMLODIPINE BESYLATE, TADALAFIL, SERTRALINE HYDROCHLORIDE, SILDENAFIL CITRATE, SILDENAFIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, OXYGEN, 0XYGEN, CALCIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, METHYLPREDNISOLONE, |
||||
| 1775 | 24853833 |
US |
78 | 1 |
Drug intolerance, General physical health deterioration, |
||||
| 1776 | 24853904 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1777 | 24853906 |
FR |
55 | 1 |
Hyperleukocytosis, C-reactive protein increased, General physical health deterioration, |
||||
CARBOPLATIN, PEMBROLIZUMAB, PEMETREXED DISODIUM, |
||||
| 1778 | 24853944 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1779 | 24853977 |
US |
||
Drug diversion, General physical health deterioration, Therapeutic response decreased, Product substitution issue, Suspected counterfeit product, |
||||
OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, |
||||
| 1780 | 24854057 |
CA |
1 | |
Prostate cancer, General physical health deterioration, |
||||
| 1781 | 24854458 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1782 | 24855011 |
CA |
2 | |
Spinal disorder, Loss of personal independence in daily activities, General physical health deterioration, Gait disturbance, Pain in extremity, Arthralgia, Eye infection, Urinary tract infection, Bronchitis, |
||||
| 1783 | 24855035 |
CA |
16 | 2 |
Weight increased, Asthma, Borderline personality disorder, Decreased immune responsiveness, Dyspnoea, Dyspnoea exertional, Exercise tolerance decreased, Fatigue, General physical health deterioration, Oral discomfort, SARS-CoV-2 test positive, Sensitivity to weather change, Skin disorder, Suicidal ideation, Oral candidiasis, Drug hypersensitivity, Urticaria, Incorrect dose administered, Back pain, Blood pressure increased, Chest discomfort, Chest pain, Chills, Cough, Deafness unilateral, Ear infection, Drug ineffective, Ear pain, Feeling abnormal, Frustration tolerance decreased, Gastrooesophageal reflux disease, Headache, Heart rate increased, Illness, Influenza, Osteoarthritis, Pain, Pneumonia, Procedural pain, Product use issue, Pruritus, Skin haemorrhage, Stress, Therapy partial responder, Tremor, Viral infection, Vitreous floaters, Weight decreased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PREDNISONE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, DULOXETINE HYDROCHLORIDE, DULOXETINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, MONTELUKAST, MONTELUKAST, PREGABALIN, PREGABALIN, DULOXETINE HYDROCHLORIDE, DULOXETINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 1784 | 24855370 |
AU |
1 | |
General physical health deterioration, Pain, Mobility decreased, Weight decreased, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 1785 | 24855422 |
CA |
82 | 1 |
General physical health deterioration, Loss of consciousness, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, FINASTERIDE, AMLODIPINE, |
||||
| 1786 | 24855445 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1787 | 24855640 |
CA |
||
Seizure, Erectile dysfunction, Asthenia, Blood testosterone decreased, Bone pain, Burning sensation, Chills, Depression, Seborrhoeic keratosis, Dyspnoea, Erythema, General physical health deterioration, Haemoglobin abnormal, Headache, Heart rate increased, Hot flush, Hyperhidrosis, Hypoaesthesia, Hypogonadism, Loss of libido, Nervousness, Osteoporosis, Pruritus, Red blood cell count decreased, Respiration abnormal, White blood cell count increased, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 1788 | 24855996 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1789 | 24855998 |
US |
||
Laboratory test abnormal, General physical health deterioration, White blood cell count decreased, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1790 | 24856361 |
TR |
81 | 2 |
Panic attack, Hallucination, Dyskinesia, Epilepsy, Epilepsy, General physical health deterioration, |
||||
| 1791 | 24856805 |
FR |
73 | 1 |
Drug abuse, Drug dependence, Fall, General physical health deterioration, Somnolence, Nausea, Bladder dilatation, Constipation, |
||||
MORPHINE, |
||||
| 1792 | 24856825 |
CA |
44 | 2 |
Abdominal discomfort, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, Colitis ulcerative, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Facet joint syndrome, Fatigue, Feeling hot, Fibromyalgia, Folliculitis, Frequent bowel movements, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver disorder, Lower respiratory tract infection, Lung disorder, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Porphyria acute, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rectal haemorrhage, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, PREDNISONE, APREPITANT, APREPITANT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, SULFASALAZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOGESTREL AND ETHINYL ESTRADIOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INDOMETHACIN, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SECUKINUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, RITUXIMAB-ABBS, RITUXIMAB-ABBS, ERGOCALCIFEROL, TOFACITINIB, TOFACITINIB, TOFACITINIB, CALCIUM GLUCONATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LORAZEPAM, QUETIAPINE FUMARATE, QUETIAPINE, FISH OIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, |
||||
| 1793 | 24856834 |
CA |
66 | 1 |
Accidental death, Erythema, General physical health deterioration, Loss of consciousness, Skin warm, Toxicity to various agents, Serotonin syndrome, Wrong patient received product, |
||||
PHENYTOIN, CLONAZEPAM, LACOSAMIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, RISPERIDONE, |
||||
| 1794 | 24857072 |
FR |
71 | 1 |
Gastrointestinal inflammation, General physical health deterioration, Hiccups, Off label use, |
||||
CAPECITABINE, CAPECITABINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, OXALIPLATIN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ROSUVASTATIN, LATANOPROST, UMECLIDINIUM, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1795 | 24857180 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1796 | 24857625 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1797 | 24857647 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1798 | 24857693 |
US |
1 | |
Thrombocytopenia, General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1799 | 24857721 |
BG |
67 | 1 |
Cardiac failure, Respiratory failure, Hepatic failure, General physical health deterioration, |
||||
CARBOPLATIN, ETOPOSIDE, |
||||
| 1800 | 24857766 |
BG |
78 | 2 |
Neutropenia, Second primary malignancy, Gastric cancer, General physical health deterioration, Weight decreased, |
||||
LETROZOLE, LETROZOLE TABLETS, PALBOCICLIB, PALBOCICLIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28